Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the

Dow Jones Industrial Average

(

^DJI

) trading up 27 points (0.2%) at 17,393 as of Tuesday, Nov. 4, 2014, 3:25 PM ET. The NYSE advances/declines ratio sits at 1,085 issues advancing vs. 1,951 declining with 143 unchanged.

The Diversified Services industry as a whole closed the day up 0.2% versus the S&P 500, which was down 0.3%. Top gainers within the Diversified Services industry included

General Employment

(

JOB

), up 21.4%,

Wilhelmina International

(

WHLM

), up 7.1%,

Bioanalytical Systems

(

BASI

), up 7.6%,

Ambassadors Group

(

EPAX

), up 3.8% and

Internet Patents

(

PTNT

), up 2.2%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Ambassadors Group

(

EPAX

TheStreet Recommends

) is one of the companies that pushed the Diversified Services industry higher today. Ambassadors Group was up $0.13 (3.8%) to $3.54 on light volume. Throughout the day, 3,750 shares of Ambassadors Group exchanged hands as compared to its average daily volume of 9,200 shares. The stock ranged in a price between $3.40-$3.57 after having opened the day at $3.41 as compared to the previous trading day's close of $3.41.

Ambassadors Group, Inc., an educational company, organizes and promotes worldwide educational travel programs for students and professional. The company's Ambassador Programs and Other segment offers educational travel services to students and professionals. Ambassadors Group has a market cap of $60.5 million and is part of the services sector. Shares are down 23.7% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Ambassadors Group a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Ambassadors Group as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on EPAX go as follows:

  • AMBASSADORS GROUP INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. The company has reported a trend of declining earnings per share over the past two years. During the past fiscal year, AMBASSADORS GROUP INC swung to a loss, reporting -$0.41 versus $0.09 in the prior year.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Hotels, Restaurants & Leisure industry. The net income has significantly decreased by 151.7% when compared to the same quarter one year ago, falling from $8.09 million to -$4.19 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Hotels, Restaurants & Leisure industry and the overall market, AMBASSADORS GROUP INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has significantly decreased to -$6.38 million or 294.18% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • In its most recent trading session, EPAX has closed at a price level that was not very different from its closing price of one year earlier. This is probably due to its weak earnings growth as well as other mixed factors. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.

You can view the full analysis from the report here:

Ambassadors Group Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

Bioanalytical Systems

(

BASI

) was up $0.18 (7.6%) to $2.50 on heavy volume. Throughout the day, 72,533 shares of Bioanalytical Systems exchanged hands as compared to its average daily volume of 6,400 shares. The stock ranged in a price between $2.22-$2.60 after having opened the day at $2.22 as compared to the previous trading day's close of $2.32.

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. Bioanalytical Systems has a market cap of $19.3 million and is part of the services sector. Shares are down 11.8% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Bioanalytical Systems a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Bioanalytical Systems as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.

Highlights from TheStreet Ratings analysis on BASI go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Life Sciences Tools & Services industry. The net income has significantly decreased by 62.7% when compared to the same quarter one year ago, falling from $0.58 million to $0.22 million.
  • Net operating cash flow has significantly decreased to $0.21 million or 75.43% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Life Sciences Tools & Services industry and the overall market, BIOANALYTICAL SYSTEMS INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • BIOANALYTICAL SYSTEMS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, BIOANALYTICAL SYSTEMS INC turned its bottom line around by earning $0.09 versus -$0.87 in the prior year.
  • 39.46% is the gross profit margin for BIOANALYTICAL SYSTEMS INC which we consider to be strong. Regardless of BASI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 3.56% trails the industry average.

You can view the full analysis from the report here:

Bioanalytical Systems Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Wilhelmina International

(

WHLM

) was another company that pushed the Diversified Services industry higher today. Wilhelmina International was up $0.40 (7.1%) to $6.00 on light volume. Throughout the day, 200 shares of Wilhelmina International exchanged hands as compared to its average daily volume of 2,200 shares. The stock ranged in a price between $5.48-$6.00 after having opened the day at $5.48 as compared to the previous trading day's close of $5.60.

Wilhelmina International has a market cap of $32.9 million and is part of the services sector. Shares are down 6.7% year-to-date as of the close of trading on Monday.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.